ALT-803

Interleukin-15 super-agonist

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for ALT-803, covering 2020-08-12 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer [Phase 1, Phase 2]

See pricing